| 中國文化大學 |
2010-12 |
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals
|
Wu, S (Wu, Semon); Hsu, LA (Hsu, Lung-An); Teng, MS (Teng, Ming-Sheng); Lin, JF (Lin, Jeng Feng); Chang, HH (Chang, Hsien-Hsun); Chang, PY (Chang, Pi-Yueh); Hu, CF (Hu, Chiao-Feng); Ko, YL (Ko, Yu-Lin) |
| 中山醫學大學 |
2014-07-19 |
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
|
CW, Lin; SF, Yang; CY, Chuang; HP, Lin; CH, Hsin |
| 亞洲大學 |
2018-04 |
Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan
|
Liang-Chun, S;Shih, Liang-Chun;Li, Ching-Hao;Li, Ching-Hao;Sun, Kuo-Ting;Sun, Kuo-Ting;Che, Liang-Yu;Chen, Liang-Yu;Hsu, Che-Lun;Hsu, Che-Lun;Hung, Yi-Wen;Hung, Yi-Wen;Wu, Cheng-Nan;Wu, Cheng-Nan;Hsia, Te-Chun;Hsia, Te-Chun;Shen, Te-Chun;Shen, Te-Chun;Cha, Wen-Shin;Chang, Wen-Shin;Sh, Tzu-Ching;Shih, Tzu-Ching;Tsa, Chia-Wen;Tsai, Chia-Wen;包大?;Bau, Da-Tian;* |
| 亞洲大學 |
2018-10 |
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer
|
LI, CHENG-HSI;LIAO, CHENG-HSI;CHA, WEN-SHIN;CHANG, WEN-SHIN;TSA, CHIA-WEN;TSAI, CHIA-WEN;HU, PEI-SHIN;HU, PEI-SHIN;WU, HSI-CHIN;WU, HSI-CHIN;HSU, SHIH-WEI;HSU, SHIH-WEI;GUAN-LIANG, C;CHEN, GUAN-LIANG;YUE, TE-CHENG;YUEH, TE-CHENG;SHEN, TE-CHUN;SHEN, TE-CHUN;HSIA, TE-CHUN;HSIA, TE-CHUN;包大?;Bau, Da-Tian |
| 亞洲大學 |
2018-09 |
Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer
|
TSUNG-HSUN, TSUNG-HSUN T;TSAI, TSUNG-HSUN;WAN, YAO-MING;WANG, YAO-MING;CHA, WEN-SHIN;CHANG, WEN-SHIN;TSA, CHIA-WEN;TSAI, CHIA-WEN;WU, HSI-CHIN;WU, HSI-CHIN;HSU, HUAI-MEI;HSU, HUAI-MEI;WANG, YUN-CHI;WANG, YUN-CHI;LI, HSIN-TING;LI, HSIN-TING;GONG, CHI-LI;GONG, CHI-LI;包大?;Bau, Da-Tian |
| 中山醫學大學 |
2004 |
Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis.
|
Chen, KM; Lee, HH; Lu, KH; Tseng, YK; Hsu, LS; Chou, HL; Lai, SC |
| 中山醫學大學 |
2004 |
Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.
|
Lee, HH; Chou, HL; Chen, KM; Lai, SC |
| 亞洲大學 |
2019-12 |
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk
|
MING-HSIEN, W;WU, MING-HSIEN;TZEN, HUEY-EN;TZENG, HUEY-EN;WU, CHENG-NAN;WU, CHENG-NAN;YUE, TE-CHENG;YUEH, TE-CHENG;PEN, YEN-CHUN;PENG, YEN-CHUN;TSA, CHUN-HAO;TSAI, CHUN-HAO;WANG, YUN-CHI;WANG, YUN-CHI;KE, TAO-WEI;KE, TAO-WEI;PE, JEN-SHENG;PEI, JEN-SHENG;CHA, WEN-SHIN;CHANG, WEN-SHIN;包大?;Bau, Da-Tian |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Guo J.-C.; JEN-CHIEH LEE; Yang S.-H.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang, S.-H.;Lee, J.-C.;Guo, J.-C.;Kuo, S.-H.;Tien, Y.-W.;Kuo, T.-C.;Cheng, A.-L.;Yeh, K.-H.; TING-CHUN KUO; YU-WEN TIEN; JEN-CHIEH LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; YU-WEN TIEN; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; Kuo T.-C.; Tien Y.-W.; Kuo S.-H.; JEN-CHIEH LEE; Guo J.-C.; Yang S.-H.; Yang S.-H.;Jen-Chieh Lee;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-09-29T06:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; TING-CHUN KUO; Tien Y.-W.; Kuo S.-H.; Guo J.-C.; Lee J.-C.; Yang S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-08-12T04:01:25Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
YANG SHIH-HUNG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:35Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:17Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Sung-Hsin Kuo;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Lee J.-C.; Guo J.-C.; SUNG-HSIN KUO; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 國立成功大學 |
2023-4 |
Association of medications with burning mouth syndrome in Taiwanese aged patients
|
吳昱學; WU, YU-HSUEH; Wu, Yu-Hsueh;Chiang, Chun-Pin |
| 國立成功大學 |
2023 |
Association of medications with burning mouth syndrome in Taiwanese aged patients
|
Wu, Y.-H.;Chiang, Chiang C.-P. |
| 中國醫藥大學 |
2015-10 |
Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case-Control Study.
|
賴世偉(Shih-Wei Lai);林橙莉;廖光福(Kuan-Fu Liao)* |
| 國立臺灣大學 |
2010 |
Association of Metabolic Profiles with Hepatic Fibrosis in Chronic Hepatitis C Patients with Genotype 1 or 2 Infection
|
許景盛; 劉振驊; 劉俊人; 徐士哲; 陳祈玲; 黃瑞仁; 賴明陽; 陳培哲; 陳定信; 高嘉宏; HSU, CHING-SHENG; LIU, CHEN-HUA; LIU, CHUN-JEN; HSU, SHIH-JER; CHEN, CHI-LING; HWANG, JUEY-JEN; LAI, MING-YANG; CHEN, PEI-JER; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T08:13:47Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S. and Liu, C.-H. and Liu, C.-J. and Hsu, S.-J. and Chen, C.-L. and Hwang, J.-J. and Lai, M.-Y. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; JUEY-JEN HWANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:32:00Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:49Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2010 |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu S.-J.; Liu C.-H.; Liu C.-J.; Hsu C.-S.; Kao J.-H.; Chen D.-S.; Lai M.-Y.; Chen P.-J.; HWANG, JUEY-JEN; Chen C.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:50Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; CHEN-HUA LIU; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:22Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-25T05:10:35Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; CHI-LING CHEN; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 美和科技大學 |
2023-09-05 |
Association of Metabolic Syndrome and Other Factors with the Presence of Diabetic Nephropathy in Type 2 Diabetic Patients
|
李昭憲 |
| 中山醫學大學 |
2021 |
Association of Metabolic Syndrome with Aerobic Exercise and LPL rs3779788 Polymorphism in Taiwan Biobank Individuals
|
Hsu, CS; Chang, ST; Nfor, ON; Lee, KJ; Ho, CC; Liu, CC; Lee, SS; Liaw, YP |
| 國立臺灣大學 |
2007 |
Association of Metabolic Syndrome with Proximal and Synchronous Colorectal Neoplasm
|
邱瀚模; 林肇堂; 孫家棟; 梁金銅; 李宜家; 黃世貝; 吳明賢; CHIU, HAN-MO; LIN, JAW-TOWN; SHUN, CHIA-TUNG; LIANG, JIN-TUNG; LEE, YI-CHIA; HUANG, SHIH-PEI; WU, MING-SHIANG |
| 臺大學術典藏 |
2018-09-10T06:15:06Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu, H. and Lin, J. and Shun, C. and Liang, J. and Lee, Y. and Huang, S. and Wu, M.; HAN-MO CHIU; Jin-Tung Liang; YI-CHIA LEE; MING-SHIANG WU; CHIA-TUNG SHUN |
| 臺大學術典藏 |
2021-03-18T02:03:09Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; CHIA-TUNG SHUN; Liang J.; Lee Y.; Huang S.; Wu M. |
| 臺大學術典藏 |
2020-11-02T02:05:12Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; Shun C.; Liang J.; Lee Y.; Huang S.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:22:10Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; Shun C.; Liang J.; Lee Y.; Huang S.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T05:45:46Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.;Lin J.;Shun C.;Liang J.;Yi-Chia Lee;Huang S.;Wu M.; Chiu H.; Lin J.; Shun C.; Liang J.; YI-CHIA LEE; Huang S.; Wu M. |
| 臺大學術典藏 |
2021-02-03T03:56:52Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
HAN-MO CHIU; Lin J.; Shun C.; Liang J.; Lee Y.; Huang S.; Wu M. |
| 臺大學術典藏 |
2021-05-03T02:21:15Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; Shun C.; JIN-TUNG LIANG; Lee Y.; Huang S.; Wu M. |
| 臺大學術典藏 |
2022-09-06T07:43:45Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; Shun C.; Liang J.; Lee Y.; Huang S.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-07T06:50:49Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
Chiu H.; Lin J.; Shun C.; Liang J.; YI-CHIA LEE; Huang S.; Wu M. |
| 臺大學術典藏 |
2022-09-07T07:42:06Z |
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
|
HAN-MO CHIU; Lin J.; Shun C.; Liang J.; Lee Y.; Huang S.; Wu M. |
| 臺大學術典藏 |
2019-12-19T08:05:13Z |
Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program
|
Lee, Ming-Chia; Lee, Chih-Hsin; Zhang, Jun-Fu; Wang, Jann-Yuan; Chen, Shih-Ming;MENG RUI LEE;CHIA HAO CHANG;LIH-YU CHANG; LIH-YU CHANG; CHIA HAO CHANG; MENG RUI LEE; Lee, Ming-Chia; Lee, Chih-Hsin; Zhang, Jun-Fu; Wang, Jann-Yuan; Chen, Shih-Ming |
| 臺大學術典藏 |
2020-08-13T05:23:59Z |
Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program
|
Lee M.-C.;Lee C.-H.;Chang L.-Y.;Chang C.-H.;Zhang J.-F.;Lee M.-R.;Jann-Yuan Wang;Chen S.-M.; Lee M.-C.; Lee C.-H.; Chang L.-Y.; Chang C.-H.; Zhang J.-F.; Lee M.-R.; JANN-YUAN WANG; Chen S.-M. |
| 臺大學術典藏 |
2021-01-08T01:57:13Z |
Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program
|
MENG-RUI LEE; Lee M.-C.; Lee C.-H.; Chang L.-Y.; Chang C.-H.; Zhang J.-F.; Wang J.-Y.; Chen S.-M. |
| 臺大學術典藏 |
2021-09-17T02:50:55Z |
Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program
|
Lee M.-C.; Lee C.-H.; Chang L.-Y.; Chang C.-H.; Zhang J.-F.; MENG-RUI LEE; Wang J.-Y.; Chen S.-M. |
| 中山醫學大學 |
2021 |
ASSOCIATION OF METFORMIN WITH TOTAL JOINT REPLACEMENT DUE TO OSTEOARTHRITIS AMONG PATIENTS WITH TYPE 2 DIABETES - A 14 YEARS POPULATION-BASED REAL WORLD COHORT STUDY
|
Zhu, Z; Huang, JY; Ruan, G; Chen, S; Cao, P; Zhang, Y; Hunter, DJ; Wei, JC; Ding, C |
| 臺大學術典藏 |
2018-09-10T04:04:13Z |
Association of metronidazole resistance and natural competence in Helicobacter pylori
|
JYH-CHIN YANG; CHI-TAI FANG; Yeh, Y.-C. and Chang, K.-C. and Yang, J.-C. and Fang, C.-T. and Wang, J.-T. |
